HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Streptococcus pneumoniae pep27 mutant as a live vaccine for serotype-independent protection in mice.

Abstract
Streptococcus pneumoniae (pneumococcus) is responsible for significant morbidity and mortality in worldwide. After introduction of current pneumococcal vaccines, a marked decrease in the incidence of pneumococcal disease was observed. Unfortunately, serotype shifts in carriage and disease, including capsular switch and presence of antimicrobial resistance, have been found. Here we report live attenuated vaccine strain which is avirulent and can protect from systemic and mucosal pneumococcal diseases. Pep27, an autolysis-inducing factor of S. pneumoniae is known to mediate LytA-dependent and -independent lysis and it was thus expected to effect virulence. The loss of Pep27 had a much larger than expected decrease in virulence and has made the Pep27 mutant strain sufficiently avirulent to be used as a live vaccine. The pep27 mutation unexpectedly had lower level of capsular polysaccharide than the wild type (type 2, D39) strain. Moreover, the pep27 mutant showed rapid clearance by 24 h post intranasal infection, and was not detected in lung and blood suggesting that mutant could not invade into the tissue. Even when 2×10(8)CFU were injected intravenously the mutant was not detected in the blood or brain after 4 h. Whereas 4 h after injection of 6×10(6) CFU of the wild type parent D39 strain, bacteremia was readily detected. Two dose intranasal immunizations with the live pep27 mutant in the absence of adjuvant elicited IgG antibody and serotype-independent protection against lethal intranasal challenge. Thus Pep27 was essential for virulence, and intranasal immunization with the pep27 mutant could provide protective immunity.
AuthorsEun-Hye Kim, Sang-Yoon Choi, Min-Kyoung Kwon, Thao Dang-Hien Tran, Sang-Sang Park, Kwang-Jun Lee, Song-Mee Bae, David E Briles, Dong-Kwon Rhee
JournalVaccine (Vaccine) Vol. 30 Issue 11 Pg. 2008-19 (Mar 02 2012) ISSN: 1873-2518 [Electronic] Netherlands
PMID22154770 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ltd. All rights reserved.
Chemical References
  • Antibodies, Bacterial
  • Immunoglobulin G
  • Pneumococcal Vaccines
  • Vaccines, Attenuated
Topics
  • Administration, Intranasal
  • Animals
  • Antibodies, Bacterial (blood)
  • Immunoglobulin G (blood)
  • Male
  • Mice
  • Mutation
  • Pneumococcal Infections (prevention & control)
  • Pneumococcal Vaccines (immunology)
  • Streptococcus pneumoniae (genetics, pathogenicity, ultrastructure)
  • Vaccines, Attenuated (immunology)
  • Virulence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: